ARTICLE | Clinical News
Doxorubicin Drug Eluting Bead regulatory update
January 14, 2008 8:00 AM UTC
The EC granted Orphan Drug designation for doxorubicin hydrochloride drug eluting beads from CellMed AG, a unit of Biocompatibles, to treat glioma. ...